KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $361.4 million.

  • GoodRx Holdings' Shares Outstanding (Diluted Average) fell 814.63% to $361.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $361.4 million, marking a year-over-year decrease of 814.63%. This contributed to the annual value of $392.2 million for FY2024, which is 442.17% down from last year.
  • As of Q3 2025, GoodRx Holdings' Shares Outstanding (Diluted Average) stood at $361.4 million, which was down 814.63% from $368.3 million recorded in Q2 2025.
  • Over the past 5 years, GoodRx Holdings' Shares Outstanding (Diluted Average) peaked at $423.1 million during Q2 2022, and registered a low of $361.4 million during Q3 2025.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $399.4 million, with a median of $410.0 million in 2021.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 4924.9% in 2021, then tumbled by 814.63% in 2025.
  • GoodRx Holdings' Shares Outstanding (Diluted Average) (Quarter) stood at $410.0 million in 2021, then increased by 0.7% to $412.9 million in 2022, then fell by 0.62% to $410.3 million in 2023, then decreased by 4.42% to $392.2 million in 2024, then dropped by 7.84% to $361.4 million in 2025.
  • Its last three reported values are $361.4 million in Q3 2025, $368.3 million for Q2 2025, and $379.7 million during Q1 2025.